Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",21617,196,1.15 [0.92-1.42],0.2157204863542213
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",22815,248,1.16 [0.96-1.41],0.1212143033278479
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22544,1738,1.23 [1.14-1.32],4.0223489481886046e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Candidiasis,22823,540,1.15 [1.01-1.31],0.0306582177790625
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22077,4192,1.15 [1.10-1.21],2.6684432410652753e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22027,4275,1.22 [1.17-1.28],5.75844886178015e-17
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22533,1412,1.08 [1.00-1.17],0.0554324851579778
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,22725,128,1.21 [0.92-1.58],0.1726290078782369
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20028,1291,1.19 [1.09-1.29],8.02622360230133e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19325,1575,1.29 [1.20-1.40],6.160553590648479e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,18827,338,1.30 [1.10-1.53],0.0021406498605631
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14837,2721,1.20 [1.13-1.27],8.33298507412353e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18770,497,1.45 [1.26-1.66],1.1171257240015428e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22799,1678,1.09 [1.01-1.17],0.0270757621298019
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Mycoses,22917,634,1.15 [1.02-1.30],0.0226804409904419
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22036,1230,1.25 [1.15-1.36],3.263352458615388e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22848,1427,1.16 [1.07-1.25],0.0004134671041331
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21369,248,1.17 [0.97-1.42],0.1097924322580111
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,22976,66,1.19 [0.81-1.73],0.372615823293032
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22666,1245,1.15 [1.05-1.25],0.0019299259107967
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22678,81,1.07 [0.77-1.50],0.6812465421412105
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,22910,141,1.27 [0.99-1.64],0.0626440139719856
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",22887,118,1.34 [1.02-1.77],0.0366682292508977
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21300,494,1.28 [1.12-1.47],0.0004274456133614
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21111,305,1.18 [0.99-1.40],0.0650608841937964
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21259,138,1.12 [0.86-1.45],0.3919835011396052
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,22962,50,1.81 [1.18-2.78],0.0067319004290373
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,22911,171,1.08 [0.85-1.36],0.5406421253651932
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral warts,22794,54,0.75 [0.50-1.13],0.1637519156575145
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],22818,78,1.45 [1.03-2.04],0.0329921516561503
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm,22684,259,0.97 [0.80-1.17],0.7556331485741584
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,22893,38,0.99 [0.61-1.61],0.9646279921858036
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,22878,43,0.81 [0.51-1.26],0.3453540696673641
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10922,84,1.23 [0.87-1.72],0.2384664209855816
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22516,1661,0.93 [0.86-1.00],0.0535671865136829
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of meninges,22960,65,1.32 [0.91-1.91],0.14311811428898
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,22883,78,1.05 [0.74-1.48],0.7796520691999059
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,22948,118,1.02 [0.78-1.34],0.8747071903727404
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of ovary,11984,80,0.81 [0.59-1.12],0.2089307719806588
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,22936,434,0.85 [0.73-0.98],0.0256897152592415
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Caecum,22942,378,0.87 [0.74-1.02],0.0806861644006077
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",22831,88,1.08 [0.78-1.50],0.6245343380992949
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Descending colon,22932,254,0.79 [0.66-0.96],0.0158034574121796
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Rectum,22890,405,0.93 [0.80-1.08],0.3146448676880864
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22823,673,0.93 [0.83-1.05],0.239053843379556
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,22919,536,0.86 [0.75-0.98],0.0245325175886488
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Carcinoma in situ of breast,9005,49,1.23 [0.81-1.86],0.3339601188137407
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",9048,66,1.03 [0.72-1.47],0.8861939668187476
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16390,71,0.89 [0.62-1.27],0.5089288304208978
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16419,100,0.91 [0.68-1.23],0.553164631661045
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",22919,125,1.13 [0.86-1.48],0.3871575657498627
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Haemangioma, any site",22920,122,1.12 [0.85-1.47],0.435023929113064
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Leiomyoma of uterus,11718,168,1.01 [0.81-1.27],0.9015366702919704
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Lung cancer and mesothelioma,14514,476,1.03 [0.90-1.19],0.6557054489502179
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Lymphoid leukaemia,16391,72,1.01 [0.71-1.45],0.9353986797647116
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16538,219,0.96 [0.78-1.18],0.6987568096483447
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16635,316,1.12 [0.94-1.33],0.1991928659679878
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",9129,106,0.94 [0.71-1.24],0.648626931855135
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16424,105,1.07 [0.80-1.45],0.6344611176671979
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16463,144,0.86 [0.67-1.11],0.2387148813958001
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16444,125,1.16 [0.89-1.53],0.276543214674297
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",9110,87,0.86 [0.63-1.17],0.3472341798561503
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16446,127,0.98 [0.75-1.27],0.856568594217459
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8266,970,0.93 [0.84-1.03],0.1709793713358232
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16455,136,0.82 [0.63-1.06],0.1206256351653338
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16410,91,0.91 [0.66-1.26],0.5797143906605255
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16463,144,0.64 [0.51-0.81],0.0002426611382201
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanocytic naevi,22829,178,0.98 [0.78-1.23],0.855574642705433
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanocytic naevi of trunk,22948,76,0.81 [0.58-1.15],0.2452698866689188
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanoma in situ,16369,109,0.91 [0.68-1.21],0.5051719204793028
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16441,122,0.95 [0.72-1.25],0.7085264533196534
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16516,197,1.02 [0.82-1.26],0.8765355406945539
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16643,324,1.00 [0.85-1.19],0.9748933666578254
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16444,125,0.99 [0.76-1.30],0.9633049334531238
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Other benign neoplasms of skin,22802,165,0.86 [0.68-1.08],0.1908494200907966
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",17801,1482,0.90 [0.83-0.98],0.0106018788354167
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",17880,1561,0.90 [0.84-0.98],0.0102568030032096
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22671,392,1.08 [0.92-1.25],0.3439282376020379
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,20666,162,1.44 [1.13-1.83],0.0027824952094304
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22349,70,1.45 [1.01-2.07],0.0439064482960201
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22221,3491,1.19 [1.13-1.25],3.2782833521959635e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21264,74,1.22 [0.86-1.74],0.2695309687494073
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22505,65,1.05 [0.72-1.53],0.7909857220648735
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22466,1962,1.17 [1.10-1.26],4.221634116008824e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22464,1960,1.17 [1.10-1.26],4.686985902025824e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,20621,117,1.27 [0.96-1.69],0.0942136157594329
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22618,1428,1.32 [1.22-1.43],1.1312459245187813e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22553,113,1.03 [0.78-1.37],0.8194423588620412
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22352,73,1.08 [0.76-1.54],0.6670775343190166
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22354,75,1.08 [0.76-1.54],0.6634680510306288
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,22797,357,1.41 [1.20-1.66],2.3735651712355847e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,22850,40,1.08 [0.67-1.74],0.7598790900286998
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",22732,292,1.37 [1.15-1.64],0.0004938661017373
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21322,132,0.90 [0.69-1.17],0.4231108251167106
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15356,412,1.31 [1.13-1.53],0.0003975829427653
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21478,103,0.72 [0.52-0.98],0.0395015508097296
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21489,114,0.61 [0.46-0.81],0.0005846636151224
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,15016,72,1.34 [0.94-1.93],0.1096953514794482
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21330,65,1.43 [0.98-2.08],0.062032986332009
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20564,314,0.93 [0.79-1.11],0.4267820418080563
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22187,954,1.22 [1.11-1.35],6.790299200079069e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,21711,478,1.03 [0.90-1.18],0.6820004744816872
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21449,216,1.04 [0.85-1.29],0.681729273559319
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,22692,1427,1.08 [0.99-1.17],0.0700790085917393
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19326,1381,1.06 [0.98-1.15],0.1682502619258292
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",15034,90,1.12 [0.81-1.54],0.4926311443895619
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20684,100,0.93 [0.69-1.26],0.657799462135978
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15309,365,1.34 [1.14-1.57],0.0003399621843585
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,15001,57,1.04 [0.69-1.56],0.8518865722904008
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19516,4572,1.01 [0.97-1.06],0.5868528234639696
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15205,261,1.24 [1.03-1.50],0.0230665891884618
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15652,708,1.20 [1.07-1.35],0.0015249403955027
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,22915,367,1.29 [1.11-1.51],0.0012512594301044
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,22708,160,1.37 [1.08-1.73],0.0092614696924719
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,15098,154,1.21 [0.95-1.55],0.1269041123134184
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",15026,82,1.31 [0.94-1.83],0.1157299033058639
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22340,1756,0.99 [0.92-1.06],0.8063262654667145
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15324,380,1.51 [1.30-1.77],1.5092917281581764e-07
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15369,425,1.22 [1.05-1.41],0.0094519626221802
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15800,856,1.06 [0.96-1.18],0.2622755115742207
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,15123,179,1.50 [1.19-1.88],0.0004870464639894
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,22698,150,1.39 [1.09-1.77],0.0077592740937995
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15833,889,1.32 [1.19-1.47],7.700858978991655e-08
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15601,657,1.13 [1.01-1.28],0.036406668162748
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20327,77,0.98 [0.69-1.38],0.9110166717062512
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21339,6395,1.05 [1.01-1.09],0.0075719332921985
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20645,61,0.71 [0.49-1.03],0.0675659598369577
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20635,51,1.16 [0.76-1.78],0.4795476672766664
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22792,1890,0.95 [0.89-1.02],0.1570377560313582
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22790,1888,0.95 [0.89-1.02],0.1405687105639611
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20651,67,0.94 [0.65-1.36],0.7504122494848203
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,22623,1133,1.07 [0.98-1.17],0.13487561592477
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17173,2229,1.25 [1.17-1.33],1.0250302371197578e-11
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,22960,312,1.84 [1.55-2.18],1.7267742009609209e-12
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21365,132,1.07 [0.82-1.40],0.6201593919502868
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21609,119,1.29 [0.98-1.70],0.0735040403895693
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21654,164,1.18 [0.93-1.49],0.1768637187663752
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",15143,199,1.22 [0.99-1.51],0.0623353823842432
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20188,181,2.19 [1.75-2.73],3.2046011558709024e-12
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2463,98,1.67 [1.23-2.25],0.0008668063765855
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2634,311,1.43 [1.21-1.69],2.5086462848354604e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20091,84,2.19 [1.56-3.08],5.502034178199239e-06
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2437,75,1.93 [1.37-2.72],0.0001551204368294
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22137,2130,1.07 [1.01-1.15],0.033839207560711
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,21859,626,1.11 [0.99-1.26],0.0838226518060826
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,20698,448,1.15 [0.99-1.32],0.0589267083517392
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16052,1108,1.20 [1.09-1.31],0.0001298586092167
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",22840,299,1.28 [1.08-1.53],0.0051177039304684
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21495,268,1.22 [1.01-1.48],0.0364569457314055
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Angina pectoris,19844,1557,1.06 [0.98-1.15],0.1171174364096903
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21598,371,1.18 [1.00-1.38],0.0455838632869763
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21316,89,1.28 [0.93-1.77],0.1325338290617931
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21517,290,1.18 [0.99-1.41],0.0670274525069342
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11609,2796,1.10 [1.04-1.17],0.0011794398829302
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,AV-block,17470,677,1.27 [1.13-1.43],8.53885220914287e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22892,570,1.05 [0.93-1.20],0.4312668874841218
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiac arrest,9080,267,1.56 [1.29-1.89],3.85292774148991e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,16996,203,1.21 [0.98-1.50],0.0809165721247437
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",16903,110,1.02 [0.76-1.36],0.9183733924480306
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,22971,77,1.06 [0.75-1.50],0.7392896004676521
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Conduction disorders,18339,1546,1.23 [1.14-1.33],1.3840644894485486e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20994,2732,1.01 [0.95-1.07],0.7308701621778836
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18434,8826,1.01 [0.98-1.05],0.382933368944745
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21416,329,1.30 [1.10-1.53],0.0023166293947146
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Endocarditis,16893,100,1.28 [0.94-1.74],0.1191944676388464
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22686,1648,1.25 [1.16-1.34],8.221205708066535e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertension,19665,7858,1.00 [0.97-1.04],0.8663016346929578
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19684,7877,1.01 [0.97-1.04],0.7724584315533988
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",22807,92,1.50 [1.09-2.07],0.0118687224855265
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12065,258,1.43 [1.18-1.73],0.0002936045629606
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12014,207,2.10 [1.70-2.60],1.0642117973733535e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypotension,22792,1641,1.26 [1.17-1.35],2.294715228214132e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,21686,150,1.07 [0.84-1.38],0.5776113743780775
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21163,2876,1.02 [0.96-1.08],0.5869701162637346
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22460,797,1.13 [1.02-1.26],0.0222501752877932
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17316,523,1.16 [1.02-1.33],0.0282436463811409
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22279,1057,0.99 [0.91-1.09],0.9133551278092488
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19198,911,1.01 [0.92-1.12],0.8027730875081758
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",22845,188,0.96 [0.77-1.20],0.7229585061658531
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",22931,410,1.06 [0.92-1.24],0.4177094780069111
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Oesophageal varices,21152,65,1.49 [1.02-2.17],0.0385489808369239
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other aneurysm,21332,105,1.06 [0.78-1.43],0.7194164087706383
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,17382,589,1.16 [1.02-1.32],0.0206893459702199
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21361,134,1.11 [0.85-1.45],0.4289169722917879
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21554,327,1.25 [1.05-1.47],0.0103766870666995
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,17009,216,1.11 [0.90-1.37],0.3374120624406095
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other disorders of veins,21205,118,1.19 [0.90-1.57],0.2250240012491847
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21131,44,0.92 [0.58-1.46],0.7345246931056433
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,20929,91,0.87 [0.63-1.20],0.3819448407844293
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21268,181,1.35 [1.08-1.68],0.0088720647267758
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18247,1454,1.21 [1.11-1.31],4.323454055906308e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21214,63,1.54 [1.05-2.26],0.0260816021918284
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21952,725,1.24 [1.11-1.39],0.0001834687766501
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22199,522,1.43 [1.26-1.63],9.092870676803385e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",21811,973,1.16 [1.06-1.28],0.0023541934703044
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9230,417,1.24 [1.07-1.45],0.0046910337688222
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21785,593,1.22 [1.08-1.39],0.0014195280281847
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21503,416,1.26 [1.09-1.46],0.0022954066023136
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22280,603,1.19 [1.05-1.35],0.0055550753111318
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22875,965,1.17 [1.06-1.29],0.0013455186135793
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17301,508,1.35 [1.17-1.54],2.110633936760789e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22192,515,1.43 [1.26-1.64],9.95439695309325e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21099,261,1.23 [1.02-1.49],0.0300911817581754
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22445,909,1.12 [1.01-1.24],0.0292735497998848
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22430,949,1.10 [1.00-1.22],0.0503859694897771
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,21651,61,0.93 [0.63-1.37],0.7077672560073529
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21330,103,0.89 [0.65-1.20],0.4314680206389996
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,21989,326,1.10 [0.93-1.30],0.2774977173141416
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21555,333,1.06 [0.89-1.25],0.5177543392323873
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Varicose veins,21600,513,1.20 [1.05-1.37],0.0084486583659372
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21246,123,1.21 [0.92-1.59],0.1683361506861063
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22696,943,1.22 [1.11-1.35],6.453633735860842e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22894,332,0.74 [0.63-0.87],0.0004182599003384
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19619,1378,1.10 [1.01-1.19],0.0273321843553915
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Any mental disorder,22442,4201,1.03 [0.99-1.08],0.1573432285132741
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22866,392,0.73 [0.63-0.85],7.442770380366023e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19694,1453,1.07 [0.99-1.16],0.1028718100471539
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18327,86,1.17 [0.84-1.62],0.3477938627284627
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Smoking dependency,22464,1172,0.99 [0.91-1.09],0.9055833071909348
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19686,1445,0.97 [0.89-1.05],0.4203351846566237
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Vascular dementia,22083,233,1.27 [1.04-1.55],0.0197864937981828
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Alzheimer disease,22973,584,1.08 [0.95-1.22],0.2476137312705471
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",14069,111,1.15 [0.86-1.54],0.3605008948084448
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Bell's palsy,21132,84,1.30 [0.94-1.80],0.114593494139907
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21537,489,0.97 [0.85-1.12],0.6999988786684134
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral cysts,22525,244,0.99 [0.81-1.20],0.8863988543625229
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22898,411,1.17 [1.01-1.36],0.0383720979377251
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22130,76,0.94 [0.66-1.34],0.7372844885058343
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,22954,69,0.86 [0.60-1.24],0.4178032771556634
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22365,84,1.18 [0.84-1.65],0.3376531267199827
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Epilepsy,21475,304,1.13 [0.95-1.35],0.1604189500014201
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22519,1348,1.15 [1.06-1.25],0.0007220633537844
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,22920,915,1.12 [1.02-1.24],0.0231488944166667
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22320,3435,1.14 [1.08-1.20],5.585924913733519e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Generalized epilepsy,22598,53,1.93 [1.28-2.91],0.0016909544831533
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Hemiplegia,22822,335,1.24 [1.05-1.46],0.0110122128891368
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Hydrocephalus,22355,74,0.73 [0.52-1.02],0.0665865325888355
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,22960,73,0.80 [0.57-1.13],0.2109630061183371
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21115,67,1.01 [0.70-1.46],0.9543209777660726
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21119,71,1.11 [0.77-1.59],0.574602007043455
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Memory loss,21832,143,1.16 [0.90-1.50],0.257756542579344
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Migraine,21446,275,1.12 [0.94-1.35],0.206202539389525
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",22927,254,1.09 [0.90-1.31],0.3829096386735905
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Motor neuron disease,14152,170,1.07 [0.84-1.36],0.5765099820381676
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,22840,59,1.06 [0.72-1.58],0.7615610617303143
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22268,1220,1.04 [0.95-1.13],0.380906699088442
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Neurological diseases,21498,4330,1.07 [1.02-1.12],0.0027115247440734
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22374,320,1.23 [1.04-1.46],0.0177401840705975
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21467,419,1.03 [0.89-1.20],0.6599059077746969
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",22894,351,1.36 [1.16-1.60],0.000197307729555
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17181,968,1.14 [1.04-1.26],0.0072840148503617
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22366,85,1.07 [0.77-1.49],0.666386059225337
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22441,160,1.17 [0.92-1.48],0.2077737936268451
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22242,237,1.13 [0.93-1.38],0.2159762690394281
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21144,96,1.32 [0.97-1.79],0.0780339109213522
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other headache syndromes,21220,49,1.07 [0.70-1.64],0.7495836719148135
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other neurological diseases,22858,577,1.02 [0.90-1.15],0.8004239178577363
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other sleep disorders,21684,513,1.20 [1.05-1.37],0.0084344476361731
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Parkinson's disease,22939,677,1.08 [0.96-1.22],0.1907689863956403
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22323,42,0.79 [0.51-1.25],0.3183911732630871
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Restless leg syndrome,22973,109,1.06 [0.80-1.42],0.6773404198519573
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Sleep apnoea,22744,436,1.16 [1.00-1.34],0.0443673307775022
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22604,61,1.93 [1.31-2.85],0.0009579943207271
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,22961,199,1.00 [0.81-1.25],0.977244137099015
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21118,70,0.85 [0.60-1.22],0.3819753984284255
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,22973,590,1.07 [0.94-1.21],0.2863621684558357
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22024,227,1.28 [1.04-1.56],0.0188097116935179
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22329,152,1.08 [0.84-1.38],0.5341919894734403
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22520,557,1.07 [0.94-1.22],0.3046283630730666
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22718,268,1.77 [1.47-2.12],9.289330119862335e-10
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,21751,69,0.87 [0.60-1.25],0.4578558634676584
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,21721,39,1.09 [0.67-1.78],0.7351763643277465
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",22854,72,1.04 [0.73-1.49],0.8243295388450422
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,22660,222,0.93 [0.76-1.14],0.494366899053806
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2441,76,2.02 [1.44-2.84],4.527959130256845e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3014,112,1.70 [1.28-2.24],0.0001992402769903
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22284,107,0.88 [0.66-1.18],0.3904014643709546
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22680,1421,1.18 [1.09-1.28],3.965781520708666e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22562,880,0.99 [0.89-1.09],0.8086745184577044
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,21985,303,0.89 [0.75-1.05],0.1674783988564357
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22899,936,1.01 [0.92-1.12],0.7797752324839852
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,22967,76,1.21 [0.86-1.72],0.277924161057234
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,22825,862,1.05 [0.94-1.16],0.3821755083736002
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",22930,492,1.02 [0.89-1.16],0.8168747781810438
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,22854,226,1.01 [0.82-1.23],0.9421290849437968
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,21780,98,1.08 [0.79-1.48],0.6166839239070632
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,21785,103,1.10 [0.81-1.49],0.5357378776982157
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,21760,78,0.75 [0.53-1.04],0.087354398394199
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22844,999,1.06 [0.97-1.17],0.1990312543814109
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22104,259,0.92 [0.76-1.11],0.359347705138332
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22032,69,1.03 [0.72-1.47],0.8877351286630142
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22559,121,1.03 [0.78-1.36],0.8287732121507614
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,22824,386,0.99 [0.85-1.15],0.8526319381343508
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22180,217,1.06 [0.86-1.31],0.5666228555819164
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,22771,143,1.18 [0.92-1.52],0.1917028612362513
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22516,671,1.11 [0.99-1.25],0.0846816400921677
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22336,159,1.00 [0.79-1.27],0.9835943825586004
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20530,3226,1.12 [1.06-1.18],4.3514977398820574e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,22778,340,0.99 [0.84-1.17],0.9443511676216764
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,22958,188,1.33 [1.07-1.66],0.0115830406557412
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22220,538,0.99 [0.87-1.13],0.883811637478307
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22526,88,1.00 [0.72-1.38],0.9851009956685144
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,22959,68,1.22 [0.84-1.76],0.2930976993191364
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,21809,127,1.18 [0.90-1.54],0.2362506189979051
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,21855,173,1.03 [0.81-1.29],0.8267516675404604
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21426,167,1.04 [0.82-1.31],0.7582439579930438
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22026,63,0.70 [0.49-1.01],0.0551509066275085
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21332,73,1.06 [0.74-1.52],0.747058639030911
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,21957,112,1.25 [0.94-1.66],0.1206221120831916
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22134,289,0.96 [0.80-1.15],0.6488491541751579
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,21842,160,0.86 [0.67-1.09],0.2000167562865368
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21352,93,1.27 [0.92-1.74],0.1436119296094459
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21390,131,1.24 [0.95-1.62],0.1133791534713295
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20027,2723,1.12 [1.06-1.19],0.0001068640209509
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,21776,94,0.76 [0.56-1.03],0.0780547449067129
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22678,501,0.97 [0.85-1.11],0.6850244896825066
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22257,80,0.93 [0.66-1.30],0.670703705416875
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22387,210,1.15 [0.93-1.42],0.1967011031570131
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,22749,113,0.94 [0.71-1.24],0.6454680362778227
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,22927,138,0.95 [0.73-1.23],0.7114360376081096
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,22836,116,1.28 [0.96-1.69],0.0881104865774382
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,22700,64,0.83 [0.57-1.21],0.338206389777836
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,22706,70,1.02 [0.71-1.47],0.898166593825169
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,22867,1238,1.05 [0.97-1.15],0.2400278973041011
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22565,936,1.08 [0.98-1.20],0.1111332957090351
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,21781,152,1.23 [0.96-1.57],0.1054215377917941
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,21718,89,0.77 [0.56-1.06],0.1113332414216828
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Acute pharyngitis,22781,66,0.84 [0.58-1.22],0.3658526354772534
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,22901,186,1.18 [0.95-1.48],0.135277665836934
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,22776,61,1.35 [0.91-1.99],0.1337729436244725
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,All influenza,20304,159,1.80 [1.42-2.29],1.551133419244843e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20301,156,1.78 [1.40-2.27],2.7963551470020664e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),14142,104,0.93 [0.69-1.25],0.6267102062977999
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Allergic rhinitis,22867,237,0.99 [0.81-1.20],0.8902720790265346
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15358,1711,0.99 [0.92-1.07],0.7985828811858824
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15727,1689,0.99 [0.92-1.06],0.7349972012736558
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22457,178,1.16 [0.93-1.46],0.1948960127225983
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20250,105,1.18 [0.87-1.59],0.2877424944622967
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Bronchiectasis,19250,510,1.38 [1.21-1.58],2.5398448779638382e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",18810,70,0.97 [0.67-1.39],0.8475906888412459
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21857,3117,1.09 [1.03-1.15],0.0021818380291805
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",21755,72,0.78 [0.55-1.11],0.1641460737692658
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,21819,136,0.88 [0.68-1.14],0.3185296841908465
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22684,1625,1.18 [1.09-1.27],2.472256703404836e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,21762,79,0.81 [0.58-1.14],0.2305882601906533
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20843,6094,1.09 [1.05-1.14],1.0828528211294537e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22017,334,0.88 [0.75-1.04],0.1298482962245587
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Early onset COPD,21166,107,1.50 [1.12-2.01],0.00658624551854
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Emphysema,19172,432,1.36 [1.17-1.57],4.556855953625163e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21676,449,1.82 [1.58-2.10],1.6425701147324532e-16
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22714,2569,1.19 [1.12-1.27],7.742303445593156e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,21718,491,1.80 [1.57-2.06],3.1568129850905984e-17
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Later onset COPD,22456,1518,1.16 [1.07-1.25],0.0002929543889087
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,22956,495,1.18 [1.03-1.35],0.0201682956699765
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Nasal polyp,21781,98,0.83 [0.61-1.12],0.2248087340831129
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22694,1292,1.36 [1.25-1.48],6.565721170027084e-13
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,22682,2677,1.13 [1.07-1.20],2.54062457749104e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22433,750,0.92 [0.82-1.03],0.1428302198256217
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other pleural conditions,20071,66,1.06 [0.72-1.55],0.7659521233357324
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22855,587,1.67 [1.47-1.89],7.942858682893304e-16
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22842,1712,1.09 [1.01-1.17],0.0258855883252961
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pleural effusion,21363,1358,1.17 [1.08-1.28],0.000136674187869
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pleural plaque,20259,254,1.30 [1.07-1.58],0.0078504998945328
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22428,2283,1.19 [1.12-1.27],5.560119877537996e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,22849,388,1.20 [1.03-1.41],0.0189254642728149
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pneumothorax,20173,168,1.23 [0.97-1.56],0.086956831073182
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pollen allergy,22961,201,0.98 [0.79-1.22],0.8802268759708187
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pulmonary oedema,22359,91,1.34 [0.98-1.83],0.0713870905553045
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,14108,70,1.28 [0.89-1.85],0.186157816191781
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22670,1268,1.38 [1.27-1.50],1.0804450443743836e-13
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,21922,239,0.98 [0.81-1.19],0.8528959628959468
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Viral pneumonia,20445,300,1.27 [1.06-1.51],0.0091240178353567
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22466,240,1.15 [0.94-1.39],0.1772848426418233
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7307,118,1.12 [0.84-1.49],0.4282228940693539
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14532,61,1.20 [0.81-1.78],0.3551455574903777
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute appendicitis,22857,129,1.11 [0.85-1.45],0.4603885969912941
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute gastritis,15964,104,1.17 [0.87-1.59],0.2994885306860427
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,20940,198,1.12 [0.90-1.39],0.2935673227698498
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute peritonitis,22477,109,1.06 [0.79-1.41],0.711499081520971
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22000,61,0.87 [0.58-1.29],0.4893867419606899
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Barrett oesophagus,16366,506,1.14 [0.99-1.30],0.0641049508153874
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",20886,144,1.39 [1.08-1.79],0.011555542148518
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22552,144,1.37 [1.07-1.77],0.0139615441120218
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Cholecystitis,20961,219,1.18 [0.96-1.45],0.1187401794226969
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Cholelithiasis,21795,1053,1.02 [0.93-1.12],0.6666990075815996
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Chronic gastritis,16202,342,1.08 [0.92-1.28],0.3436290512474123
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,20798,56,1.21 [0.81-1.82],0.3570628351799243
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",22837,122,1.52 [1.16-2.01],0.0026085549135592
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Coeliac disease,21233,128,1.84 [1.41-2.40],7.161824946226665e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Collagenous colitis,21227,100,1.39 [1.03-1.88],0.0331135013393839
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,22857,154,0.94 [0.74-1.20],0.6349190091000438
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Constipation,22690,2119,1.09 [1.02-1.17],0.0078302317117204
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Crohn disease,21216,89,1.14 [0.83-1.58],0.4156425610449004
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22622,68,1.05 [0.72-1.51],0.8128593898734269
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21208,81,1.03 [0.74-1.45],0.8556896213891361
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Dental caries,22357,189,1.17 [0.94-1.45],0.1634649456063557
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,19852,2540,1.09 [1.03-1.16],0.0036068309686088
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of appendix,22886,158,1.03 [0.81-1.31],0.8225641563087585
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of liver,22853,914,1.10 [1.00-1.22],0.0525429223528427
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20423,4563,1.09 [1.04-1.14],0.0001158914120591
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22639,471,1.16 [1.01-1.33],0.0400135393456203
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22881,513,1.07 [0.93-1.22],0.3355768788536595
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22259,91,1.60 [1.17-2.19],0.0036194240424882
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22133,57,0.84 [0.56-1.25],0.3843498006923675
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22634,1529,1.18 [1.10-1.28],2.132372245467311e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of tongue,22151,96,1.03 [0.75-1.40],0.8632370734279284
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22262,1520,1.05 [0.97-1.13],0.2277041072898441
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18243,3772,0.99 [0.94-1.04],0.7368138218794951
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,16110,250,1.20 [0.99-1.45],0.0680897917512801
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",22880,204,1.09 [0.88-1.35],0.4176168195295511
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,22935,28,1.05 [0.59-1.87],0.8547716414567961
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22082,143,1.53 [1.19-1.97],0.0009743365382397
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14576,105,1.05 [0.77-1.41],0.7679684146061904
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,16417,557,1.10 [0.96-1.25],0.1576373261724499
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastric ulcer,16285,425,1.30 [1.12-1.50],0.0005351639116861
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18515,2655,1.07 [1.01-1.13],0.0322471681369391
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16511,651,1.24 [1.10-1.40],0.0004359054623854
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16579,8179,1.03 [0.99-1.06],0.1335805755193536
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,GI-bleeding,22375,1270,1.16 [1.06-1.26],0.0008487713467066
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22213,45,1.09 [0.70-1.70],0.7042690260846982
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15464,1182,0.95 [0.87-1.04],0.2528138370188716
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22009,70,1.25 [0.87-1.80],0.2336814070248797
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Hernia,20935,3623,1.05 [1.00-1.11],0.0410561247528115
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Impacted teeth,22939,26,1.04 [0.57-1.87],0.9051883249789016
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Impaction of intestines,14548,77,1.29 [0.91-1.84],0.1484690433644771
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Inguinal hernia,18406,1094,1.00 [0.91-1.10],0.9958589721008572
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17436,124,1.02 [0.77-1.35],0.8925212175391072
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14586,115,1.18 [0.89-1.58],0.2475406791450701
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21252,147,1.82 [1.42-2.34],2.243980022400129e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14979,508,1.09 [0.95-1.25],0.2179296697936607
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,22941,337,1.03 [0.88-1.22],0.703238062062159
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,21908,781,1.08 [0.97-1.21],0.1502207148162693
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22214,1087,1.10 [1.00-1.20],0.0506273995731144
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16076,216,1.07 [0.87-1.32],0.5028770856585882
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oesophagitis,16546,686,1.14 [1.02-1.28],0.0245700721456434
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,22918,134,1.11 [0.85-1.44],0.440059521557037
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17397,85,1.00 [0.72-1.40],0.9881322979075308
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15844,1373,0.97 [0.89-1.06],0.4927460109130438
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21100,358,1.17 [1.00-1.38],0.0512302297434463
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,20890,148,0.96 [0.75-1.23],0.7568840901365389
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,16390,1919,0.97 [0.90-1.04],0.3894695648784481
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,20671,6200,1.00 [0.96-1.03],0.8100860511498527
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22112,207,1.12 [0.91-1.38],0.2829077362171232
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of liver,22695,756,1.10 [0.98-1.22],0.1066278918740508
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16626,766,1.14 [1.02-1.28],0.0187991573169743
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,20958,216,1.16 [0.94-1.42],0.1635618938771618
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22806,438,1.07 [0.93-1.24],0.3383061502313378
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,16950,1090,1.10 [1.00-1.21],0.0426054581266233
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22391,1286,1.17 [1.07-1.27],0.0004238434848689
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22348,180,1.11 [0.88-1.39],0.3734731886517528
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16635,2164,1.09 [1.02-1.16],0.0115881172271728
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18003,2143,1.14 [1.07-1.22],5.8958549694511054e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22048,109,1.47 [1.10-1.96],0.0094919711075705
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22085,958,1.09 [0.99-1.20],0.0872715210531598
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14918,447,1.07 [0.93-1.24],0.3434944496762684
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,22931,31,1.03 [0.60-1.78],0.9167992459189844
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,15086,615,1.12 [0.99-1.27],0.0762498841825636
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21263,158,1.06 [0.83-1.35],0.6573942478613097
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,22961,52,0.99 [0.65-1.49],0.9449455806652498
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22162,103,1.19 [0.88-1.60],0.2541948620865724
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Toxic colitis,21205,78,0.81 [0.58-1.14],0.2293738911790879
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16201,341,1.08 [0.91-1.27],0.3647140385654319
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,21294,167,1.18 [0.93-1.50],0.1659013138779204
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21259,132,1.39 [1.07-1.81],0.0147323306559236
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Umbilical hernia,17569,257,0.85 [0.70-1.03],0.1061990159490506
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14715,244,1.09 [0.89-1.32],0.4134437206381762
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ventral hernia,17599,287,1.13 [0.95-1.36],0.171368984735296
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Volvulus,14564,93,1.33 [0.96-1.83],0.0827249581904302
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,22867,424,1.02 [0.88-1.19],0.7700383256110064
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22609,66,0.86 [0.59-1.24],0.4064583269442285
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20421,165,0.86 [0.68-1.08],0.1898117841983672
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22342,821,1.18 [1.06-1.31],0.0018394216674648
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21666,145,1.26 [0.98-1.62],0.0742246118965117
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,20887,631,1.44 [1.27-1.62],4.074651155506162e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22629,314,1.04 [0.87-1.23],0.693247413579144
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22871,556,1.14 [1.00-1.29],0.0500609972418449
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22364,49,1.04 [0.67-1.60],0.8745434129168074
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21371,3712,1.12 [1.07-1.18],8.418721885981049e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22539,435,1.07 [0.93-1.24],0.349371279792923
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22406,302,1.07 [0.90-1.27],0.4656000062229325
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22586,1065,1.20 [1.10-1.32],9.6406274284242e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",22953,61,1.22 [0.83-1.79],0.3078277744228529
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20314,58,1.88 [1.28-2.75],0.0011959624068263
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22167,63,1.35 [0.92-1.98],0.1240965732307415
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22615,300,1.03 [0.86-1.22],0.7658831822881845
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,20861,605,1.10 [0.97-1.25],0.1263355439330236
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20345,89,1.01 [0.73-1.40],0.9506808410475652
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,22883,95,1.30 [0.95-1.77],0.1006931852714682
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,21751,230,1.56 [1.28-1.91],1.1101930615778087e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22767,224,1.29 [1.05-1.58],0.013689914376578
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22411,96,1.68 [1.23-2.28],0.0009461450448159
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20333,77,1.49 [1.05-2.10],0.0251321376137583
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22361,2105,1.18 [1.10-1.26],1.9240256665962924e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",20905,649,1.10 [0.98-1.25],0.107141943165142
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20349,93,1.00 [0.73-1.38],0.9809547711232895
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,22880,337,1.20 [1.02-1.42],0.0280400206930405
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22390,75,1.04 [0.74-1.47],0.8204551675014218
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22817,274,1.17 [0.98-1.41],0.0905281939073944
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22899,456,1.04 [0.90-1.20],0.5826936857811089
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20378,122,0.75 [0.58-0.98],0.0368554828662207
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20591,335,0.99 [0.84-1.17],0.9332972260617124
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22888,445,1.02 [0.89-1.18],0.7464502026864943
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20594,338,1.68 [1.42-1.97],6.279003755288731e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,22945,157,1.06 [0.84-1.36],0.6131159492155558
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19135,80,1.19 [0.85-1.66],0.3173924962589807
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20237,6403,1.01 [0.98-1.05],0.4671591117764262
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18845,5011,1.02 [0.97-1.06],0.430421942485827
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19108,53,0.85 [0.56-1.29],0.4579591260729169
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19052,145,1.30 [1.01-1.67],0.044101636500679
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19097,190,1.28 [1.03-1.60],0.0264311570512547
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,22716,64,1.18 [0.81-1.72],0.3851161539512302
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",19059,152,1.20 [0.94-1.54],0.150038040748013
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15308,1474,1.05 [0.97-1.13],0.2653991645350553
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",22762,245,1.26 [1.04-1.53],0.0179547923368649
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19484,577,1.16 [1.02-1.31],0.0224868731762601
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18580,7985,1.04 [1.00-1.07],0.0413730014363299
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20440,120,1.17 [0.89-1.54],0.2713469555717699
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,19235,180,1.19 [0.95-1.49],0.1365072775570293
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19558,503,1.03 [0.90-1.18],0.6563574562105294
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22039,3132,1.10 [1.04-1.16],0.000537760432605
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19365,310,0.93 [0.78-1.11],0.4184853616110261
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19202,147,1.02 [0.80-1.30],0.8807544223673238
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19169,114,1.03 [0.78-1.36],0.8460084687448663
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22224,101,0.95 [0.70-1.27],0.7186860311851546
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15834,2000,0.92 [0.86-0.98],0.0149916149849458
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14619,785,0.94 [0.84-1.05],0.3010020430568738
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22880,778,0.94 [0.84-1.05],0.2550958864868126
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,13912,78,1.16 [0.82-1.63],0.4108317162639489
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14135,301,0.89 [0.75-1.06],0.2024589368638581
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19320,265,0.99 [0.82-1.19],0.8759100779490309
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14315,481,0.94 [0.82-1.08],0.3686010427987515
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,18987,80,1.71 [1.22-2.39],0.0018716422161432
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19593,686,1.07 [0.95-1.20],0.2471857463015063
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19220,313,0.96 [0.81-1.13],0.609768052726139
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14284,450,0.93 [0.81-1.07],0.3092520804632838
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19127,72,1.00 [0.70-1.43],0.9889842893197976
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19115,60,1.03 [0.69-1.52],0.8955215650576966
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20405,85,1.74 [1.25-2.42],0.0009525653722327
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22542,2222,1.19 [1.12-1.27],6.311399268199244e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,21888,1568,1.21 [1.12-1.31],7.497140949731551e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22799,540,1.07 [0.94-1.21],0.3260235219280281
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16957,3123,1.05 [0.99-1.10],0.1007022742388176
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,13876,42,0.99 [0.62-1.59],0.9792914888807612
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19158,103,1.06 [0.78-1.42],0.7240459735316599
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,13905,71,0.88 [0.61-1.27],0.4954724855794299
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),13969,135,1.03 [0.79-1.33],0.835388980253965
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20558,238,0.95 [0.78-1.16],0.6299150255587993
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,20825,505,1.29 [1.13-1.47],0.0002118038675884
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,22949,113,1.21 [0.91-1.61],0.187353719709039
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20884,1977,1.11 [1.04-1.19],0.0029356433936477
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19130,75,0.84 [0.60-1.19],0.3282024350702956
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),13984,150,0.98 [0.77-1.25],0.870768532640109
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19693,786,1.09 [0.98-1.22],0.1136781494359386
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,16006,2172,1.01 [0.95-1.08],0.6778451600840925
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22250,127,1.04 [0.79-1.35],0.792360116298543
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,22961,63,0.93 [0.64-1.36],0.6992175097798432
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19133,78,1.15 [0.82-1.63],0.4121162372778886
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20399,1344,1.09 [1.00-1.18],0.0487782615939753
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19162,107,1.16 [0.86-1.55],0.3284913983621773
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15891,2057,1.05 [0.98-1.12],0.1631689217254749
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20434,114,0.85 [0.64-1.13],0.2695234473199741
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19093,38,1.17 [0.72-1.91],0.5242848428814582
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,19103,196,1.31 [1.05-1.62],0.0145578097761533
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19732,677,1.12 [1.00-1.26],0.051336529098878
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22615,492,1.00 [0.88-1.15],0.9721547173301148
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19565,658,1.21 [1.08-1.37],0.0012187694919073
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22814,534,1.06 [0.93-1.21],0.3569032656676807
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,22946,68,1.13 [0.78-1.64],0.507924121250785
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19220,165,0.91 [0.72-1.15],0.4398826003150907
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17859,881,1.13 [1.02-1.25],0.0173239461443116
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19698,643,1.17 [1.04-1.32],0.0100488725276136
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19334,279,0.90 [0.75-1.08],0.2719041651764549
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",13903,69,1.12 [0.78-1.62],0.5370158674397483
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16935,3101,1.01 [0.96-1.07],0.6223219236520556
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14668,834,1.11 [1.00-1.24],0.0464903498246719
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22500,377,0.93 [0.80-1.09],0.3599291231174352
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",22916,80,1.29 [0.92-1.80],0.1424549243429672
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20330,71,0.99 [0.69-1.41],0.9481889023176436
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,13898,64,0.92 [0.63-1.36],0.6858356191860124
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,19012,105,1.05 [0.78-1.42],0.7301393856382046
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14382,548,1.06 [0.93-1.21],0.3703305646882132
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19387,332,0.96 [0.81-1.13],0.6266857392230023
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19190,283,1.28 [1.07-1.53],0.0079121812272273
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,19167,260,1.19 [0.99-1.44],0.0669055362600596
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16139,67,1.13 [0.78-1.63],0.5315135872934567
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",22951,73,1.16 [0.81-1.65],0.4232948096063509
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19606,551,1.01 [0.89-1.15],0.9129872096069116
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],22214,91,1.36 [1.00-1.86],0.0514839364061669
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21679,2624,1.04 [0.98-1.11],0.1690632239854245
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19204,149,1.08 [0.85-1.38],0.5263188336480411
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19613,706,1.11 [0.99-1.24],0.0723762420603229
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21608,275,1.17 [0.98-1.40],0.0909432320628073
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,19160,253,1.08 [0.89-1.31],0.4283982738535555
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20905,1998,1.09 [1.02-1.17],0.0087202280811299
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20215,1308,1.13 [1.04-1.23],0.0048166212437241
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19116,61,1.02 [0.69-1.50],0.9372986049936434
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22238,115,1.45 [1.10-1.91],0.0078856367619903
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19215,160,1.16 [0.92-1.48],0.2135353451506224
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,19145,90,1.07 [0.78-1.46],0.6851260347444328
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),13911,77,1.40 [0.99-1.99],0.0575751822821981
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21475,2246,1.32 [1.23-1.40],5.077069077371504e-17
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9217,26,0.92 [0.52-1.63],0.7751085672070475
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11697,34,0.91 [0.55-1.50],0.706129933132809
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22642,308,0.98 [0.82-1.16],0.7956093720187927
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22438,104,0.83 [0.61-1.12],0.2263552871109342
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21547,2318,1.46 [1.37-1.56],3.113457899098382e-32
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,22738,128,1.91 [1.47-2.48],1.2666461503880914e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,22671,406,1.04 [0.89-1.21],0.619667500974243
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cystitis,19128,299,1.09 [0.91-1.30],0.3467442483032678
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Dialysis,19326,97,2.13 [1.56-2.90],1.5975954087906545e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10103,2136,1.08 [1.01-1.16],0.0184168684420319
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11799,136,0.80 [0.62-1.02],0.0663170100391103
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9231,40,0.94 [0.59-1.49],0.7883977305353617
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9774,583,0.94 [0.83-1.06],0.306867022580209
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18925,6268,1.09 [1.05-1.13],8.189070794385107e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,22706,96,2.21 [1.63-3.01],3.712213076559388e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hydrocele,8082,115,1.36 [1.02-1.82],0.0357430866212816
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19298,349,1.06 [0.89-1.25],0.5227259127399518
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9784,1817,1.11 [1.03-1.19],0.0055896055446916
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11861,160,0.82 [0.65-1.03],0.0896087711479901
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8095,128,0.88 [0.67-1.16],0.3623553191094554
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,18914,85,1.52 [1.10-2.11],0.0119481980458441
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10219,1028,0.94 [0.86-1.03],0.2106385628755969
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,8025,58,0.96 [0.64-1.44],0.8427423727572899
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9229,38,1.18 [0.74-1.90],0.4876182471084664
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",22958,89,0.91 [0.66-1.25],0.5438240371861511
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",22962,85,1.10 [0.79-1.52],0.5861054588986334
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21775,2946,1.10 [1.04-1.17],0.0006318191222782
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19766,937,1.08 [0.98-1.20],0.1284482055798333
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11714,51,0.67 [0.46-0.97],0.0328567268837109
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22892,627,1.09 [0.96-1.23],0.1883770166524188
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8116,149,1.25 [0.97-1.62],0.0794679655734254
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8127,160,1.15 [0.90-1.47],0.2653080103143129
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8121,154,0.97 [0.75-1.24],0.7885982031514924
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,22932,86,1.04 [0.75-1.44],0.8298469423903473
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21176,2347,1.15 [1.08-1.23],1.0529660033481294e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11783,82,0.82 [0.60-1.13],0.2252342865477493
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9257,66,0.71 [0.51-1.00],0.0475311854325392
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9330,139,0.78 [0.61-0.99],0.043842438560057
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9243,52,1.17 [0.78-1.77],0.449984963171267
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9288,97,0.89 [0.66-1.19],0.4227944683485467
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19359,410,1.12 [0.96-1.31],0.1435056727384993
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22465,200,1.13 [0.91-1.40],0.2829087075065185
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9317,126,1.05 [0.81-1.37],0.7002769416174263
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9216,25,1.04 [0.58-1.89],0.8859463100716659
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9402,211,0.89 [0.73-1.09],0.2693524109024253
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9282,91,1.05 [0.77-1.43],0.7764669004979126
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9395,204,1.03 [0.84-1.27],0.7724308083934879
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,22659,49,1.16 [0.75-1.80],0.4979307924310543
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8121,154,1.21 [0.94-1.55],0.1401756741224835
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22685,3736,1.28 [1.21-1.34],7.115512433680037e-22
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",19044,95,1.52 [1.12-2.08],0.0080652911718801
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19407,178,1.22 [0.97-1.54],0.0874778269411128
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22374,40,0.99 [0.61-1.60],0.9704627412232432
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19099,270,1.10 [0.91-1.33],0.3026173159434985
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22728,394,0.93 [0.80-1.08],0.3511854819666076
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9226,35,1.17 [0.72-1.91],0.5146325274341859
